Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Flurizan tarenflurbil: Additional Phase II data

Myriad Genetics Inc. (MYGN), Salt Lake City, Utah
Product: Flurizan tarenflurbil (MPC-7869)
Business: Neurology
Molecular target: Not available
Description: R-enantiomer

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE